We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Speedy Way to Identify Novel Proteins

By Biotechdaily staff writers
Posted on 15 Feb 2006
Novel protein molecules can be identified in days rather than months using a new method that relies on microscopic droplets of water suspended inside oil droplets. More...


The method uses a type of emulsion called WOW, for water-oil-water, and is modeled on living cells, which employ a fatty membrane to keep the inside and outside environments separate. The oily layer surrounding each miniscule water droplet acts as a barrier keeping genes, proteins, and other materials contained. Confining tests within a cell-like bubble enabled scientists to use a well-known method for analyzing living cells. The method involves a fluorescent marker that lights up when activated by the right protein and sorts through the cells for those containing marked proteins and their coding genes. Automated devices for sorting cells handle thousands of droplets per second.

The method was developed by Professor Shlomo Magdassi of the Hebrew University's Institute of Chemistry (Jerusalem, Israel) and Dr. Dan Tawfik and Amir Aharoni of the Weizmann Institute of Science and Technology (Rehovot, Israel) with support from the Israel Ministry of Science and Technology. Using their system, a large number of tests can be performed at once.

To demonstrate the efficiency of the system, the team isolated a new enzyme from a gene that was artificially mutated to produce random variations. They generated the enzymes in the droplets and sorted them according to those that were better at cleaving a specific enzyme in the bloodstream. The results from a screen completed in one afternoon were equivalent to those previously obtained through several rounds of mutation and screening--a process that would have taken several months.



Related Links:
Hebrew University's Institute of Chemistry
Weizmann Institute of Science and Technology

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Aspiration System
VACUSAFE
New
Steam Sterilizer
Hi Vac II Line
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.